Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06543797

A Pilot Clinical Trial Study to Determine the Safety of the Application of a Wearable Medical Electromagnetic Generator

To explore the safety of applying repetitive low-frequency transcranial magnetic stimulation using a wearable medical electromagnetic generator in stroke patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

19 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 19 to 80 years old
  • Those who are confirmed to have lesions in only one cerebral hemisphere or one brainstem on brain computed tomography (CT) or brain magnetic resonance imaging (MRI)
  • Patients with subacute stroke between 2 weeks and less than 3 months after onset
  • Motor function evaluation The total score is 0 to 56 points based on the FMA of the upper extremity on the affected side [1], and patients show impairment in upper extremity motor function.
  • After receiving a detailed explanation of this clinical trial and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to comply with the precautions.

Exclusion criteria

  • Cases accompanied by existing serious neurogenic diseases such as history of underlying stroke, brain tumor, hypoxic brain injury, epilepsy, or organic brain disease
  • Cases accompanied by existing serious psychiatric diseases such as major schizophrenia, bipolar disorder, dementia, etc., that are receiving continuous drug treatment before the stroke.
  • Those with unstable conditions in the cardiovascular, digestive, respiratory, and endocrine systems, or with severe internal diseases such as signs of systemic infection, with unstable vital signs, or with poor overall health with a life expectancy of less than 1 year.
  • Those with impaired cognitive ability (MMSE less than 10 points)
  • If there are difficulties in conducting research
  • If you have difficulty communicating
  • Other patients who are deemed difficult to participate in this study by the principal investigator.
  • Patients who are participating in other therapeutic clinical studies or who have participated in other therapeutic clinical studies within the past 30 days (observational studies are not relevant)
  • Exclusion criteria for repetitive transcranial magnetic stimulation
  • Patients with medical devices implanted in the body (e.g. pacemaker)
  • When a metal object is inserted into the skull
  • If there is a wound on the skin at the attachment site
  • History of epilepsy
  • If you have cervical pain or musculoskeletal disease
  • Pregnant and lactating women

Treatment and study plan

wearable rTMS

Device

Application of inhibitory low-frequency rTMS on unaffected primary motor cortex by wearable rTMS

Primary outcomes

  1. Safety

    Time frame: Before and after 2 weeks of intervention / Soon after every intervention

    All types of adverse events that occurred during clinical trials

Secondary outcomes

  1. Changes of Fugl-Meyer assessment

    Time frame: Before and after 2 weeks of intervention

    Fugl-Meyer assessment for motor function in score

  2. Changes of manual muscle test (MMT)

    Time frame: Before and after 2 weeks of intervention

    Manual muscle test for strength in score

  3. Changes of box and block test (BBT)

    Time frame: Before and after 2 weeks of intervention

    Box and block test for gross manual dexterity in number of blocks from on compartment of a box to another of equal size within 60 seconds

  4. Changes of action research arm test (ARAT)

    Time frame: Before and after 2 weeks of intervention

    Action research arm test for functional ability of upper extremity in score

  5. Changes of Korean mini-mental state examination (K-MMSE)

    Time frame: Before and after 2 weeks of intervention

    Korean mini mental state exam for cognitive function in score

  6. Changes of Korean version of Modified Barthel Index (K-MBI)

    Time frame: Before and after 2 weeks of intervention

    Korean version of modified barthel index for functional status in score

  7. Changes of geriatric depression scale (GDS-d)

    Time frame: Before and after 2 weeks of intervention

    Geriatric depression scale for depression in scale

  8. Changes of electroencephalograpy (EEG)

    Time frame: Before and after 2 weeks of intervention

    Electroenchphalography is a test that measures EEG power in alpha band

  9. Changes of Evoked-potentials (EP)

    Time frame: Before and after 2 weeks of intervention

    Evoked potential is an electrical potential recorded from the nervous system of a human or animal following presentation of a stimulus. In this study, motor- and sensory- evoked potentials are included.

  10. Changes of motion analysis

    Time frame: Before and after 2 weeks of intervention

    Motion analysis with motion capture setup and data processing or streaming of patients movements. In this study, data of motion capture include kinetic and kinematic data including physiological parameter.

  11. Changes of functional near-infrared spectroscopy (fNIRS)

    Time frame: Before and after 2 weeks of intervention

    Funtional near-infrared spectroscopy meausures cortical activity in concentration of oxy- and deoxy-hemoglobin

  12. Changes of blood biomarker

    Time frame: Before and after 2 weeks of intervention

    Blood biomarker include expression of tumor necrosis factor (TNF)-a and interleukin (IL)-1b

Study contacts

Contact information is provided by the study sponsor or research team.

Ye Ji Jeong, BS

CONTACT

[email protected]

+82 031 780 6003 ext. 6003

Sponsors and collaborators

Lead sponsor

Bundang CHA Hospital

Other

Registry information

Official study title

A Prospective, Single-center, Single-group, Investigator-led Exploratory Clinical Trial to Determine the Safety of the Application of a Wearable Medical Electromagnetic Generator.

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 9, 2024
Registry last updated
Aug 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.